← Back
$EIKN All transactions

Eikon Therapeutics, Inc.

A

$ Value

$0

Shares

134,088

Price

$0

Filed

Mar 4

Insider

Name

Baynes Roy D.

Title

Chief Medical Officer

CIK

0001680739

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

134,088

Footnotes

1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.

Filing Info

Accession No.

0001193125-26-091770

Form Type

4

Issuer CIK

0001861123

Baynes Roy D.'s History

Date Ticker Type Value
2026-04-14 TVTX M $144K
2026-04-14 TVTX M $139K
2026-04-14 TVTX M $82K
2026-04-14 TVTX M $96K
2026-04-14 TVTX M $115K
2026-04-14 TVTX $1.1M
2026-04-14 TVTX $284K
2026-04-14 TVTX M $0
2026-04-14 TVTX M $0
2026-04-14 TVTX M $0

Other Insiders at EIKN (90d)

Insider Bought Sold Last
Column Group IV GP, LP $38.1M 2026-02-06
Lux Venture Partners V, LLC $5.0M 2026-02-06
Wolfe Josh $5.0M 2026-02-06
FRAZIER KENNETH C $2.0M 2026-03-02
Foresite Capital Management IV, LLC $1000K 2026-02-04
PERLMUTTER ROGER M
See remarks
2026-03-02
Huffines Robert Luther 2026-03-02
Klobuchar Michael A
Chief Operating Officer
2026-03-02
Thorner Benjamin Bruno
See Remarks
2026-03-02
Bowie Alfred Lloyd Jr.
Chief Financial Officer
2026-03-02